Vice President, Engineering
Eli Lilly and Company
Dr. Johnson is VP, Engineering at Eli Lilly in Synthetic Molecule Design and Development. He was awarded the 2016 ACS Award for Affordable Green Chemistry for work with continuous aerobic oxidations, the 2016 AIChE Award for Outstanding Contribution to QbD for Drug Substance for implementation of continuous hydrogenations, Grignard formation reactions, thermal rearrangement reactions, and crystallizations. He received the 2021 AIChE CRE Practice Award for design and implementation of continuous reactors in the pharmaceutical industry. Recently his group has been applying continuous processing techniques to improve oligonucleotide syntheses.